New York State Common Retirement Fund
PRVL

New York State Common Retirement Fund’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

New York State Common Retirement Fund’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,100
Closed -$348K – 3331
2020
Q4 		$348K Sell
15,100
-600
-4% -$7.6K ﹤0.01% 2522
2020
Q3 		$160K Hold
15,700
– – ﹤0.01% 2751
2020
Q2 		$234K Buy
15,700
+6,600
+73% +$102K ﹤0.01% 2571
2020
Q1 		$111K Hold
9,100
– – ﹤0.01% 2728
2019
Q4 		$144K Buy
9,100
+8,300
+1,038% +$106K ﹤0.01% 2886
2019
Q3 		$10K Buy
+800
New +$9.06K ﹤0.01% 3215

New York State Common Retirement Fund's PRVL Position: Q1 2021 in Review

New York State Common Retirement Fund sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 15,100 shares — an estimated $348K sold.

New York State Common Retirement Fund first reported a position in PRVL in Q3 2019 and held it in 6 quarters. The position peaked at $348K in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

  • New York State Common Retirement Fund reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 15,100 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $348K.
  • New York State Common Retirement Fund first reported a position in Prevail Therapeutics Inc. Common Stock in Q3 2019 and held it in 6 quarters.
  • New York State Common Retirement Fund's Prevail Therapeutics Inc. Common Stock position peaked at $348K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on New York State Common Retirement Fund's 13F filing for Q1 2021, filed 11 May 2021.